Art

J-GLOBAL ID：200902212513353250   Reference number：09A0356098

Life-Prolonging Effect of Immunocell BRM-Activated Killer (BAK) Therapy for Highly Advanced Solid Cancer Patients: Prognostic Significance of Serum α₁ Acid Glycoprotein (α₁AG) Levels

免疫細胞BAK療法の高度進行癌に対する血清α₁AG値による介入試験

Author (1)： EBINA TAKUSABURO (仙台微生物研)
Material： Biotherapy (Tokyo)  (日本バイオセラピィ学会学術集会総会プログラム・抄録集)
Volume： 23  Issue： 2  Page： 205-210  Publication year： Mar. 30, 2009 
JST Material Number： L0028A  ISSN： 0914-2223  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *advanced cancer ,...
Semi thesaurus term： intervention trial ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0356098&from=J-GLOBAL&jstjournalNo=L0028A") }}

JST classification (2)： Immunotherapy for tumors  (GE03035B) ,  Clinical application of immunotherapeutic agents and blood preparations  (GW22020O)

Reference (15)：

• Ebina, T., Fujimiya, Y.. Yamaguchi, T., et al.: The use of BRM-activated killer cells in adoptive immunotherapy: a pilot study with nine advanced cancer patients. Biotherapy 11: 241-253, 1998.
• Fujimiya, Y., Suzuki, Y., Katakura, R., et al.: In vitro interleukin 12 activation of peripheral blood CD3⁺CD56⁺ and CD3⁺CD56^- γδT cells from glioblastoma patients. Clin. Cancer Res.3: 633-643, 1997.
• Sakamoto, J., Koike, A. Saji, S., et al.: Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK. Surg. Today 22: 530-536, 1992.
• Sakamoto, J., Teramukai, S., Koike, A., et al.: Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma: findings from three independent clinical trials. Cancer 77: 2206-2212, 1996.
• Ebina, T., Ogama, N., Shimanuki, H., et al.: Lifeprolonging effect of immunocell BAK (BRMactivated killer) therapy for advanced solid cancer patients: prognostic significance of serum immunosuppressive acidic protein levels. Cancer Immunol. Immunother.52: 555-560, 2003.

Terms in the title (7)： 免疫細胞 ,  Bak ,  療法 ,  高度 ,  進行癌 ,  血清 ,  介入試験